Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Total Non-Current Liabilities (2020 - 2021)

Historic Total Non-Current Liabilities for Rani Therapeutics Holdings (RANI) over the last 2 years, with Q4 2021 value amounting to $2.6 million.

  • Rani Therapeutics Holdings' Total Non-Current Liabilities fell 6580.31% to $2.6 million in Q4 2021 from the same period last year, while for Dec 2021 it was $2.6 million, marking a year-over-year decrease of 6580.31%. This contributed to the annual value of $2.6 million for FY2021, which is 6580.31% down from last year.
  • Per Rani Therapeutics Holdings' latest filing, its Total Non-Current Liabilities stood at $2.6 million for Q4 2021, which was down 6580.31% from $5.2 million recorded in Q3 2021.
  • In the past 5 years, Rani Therapeutics Holdings' Total Non-Current Liabilities registered a high of $9.4 million during Q2 2021, and its lowest value of $2.6 million during Q4 2021.